Managing Hypertension in Diabetes - Preferred Agents and Contemporary Goals
Course expires: 01/31/2020
This online enduring material is a recording of the live session that was held at the AACE 27th Annual Scientific Clinical Congress in Boston, MA.
- Review the results of landmark trials evaluating the benefits of intensive vs standard blood pressure control in patients with diabetes
- Discuss the benefits and drawbacks of intensive blood pressure control
- Identify individual patient factors that must be considered when setting blood pressure goals and choosing pharmaceutical agents
- Explain the AACE and ADA guideline recommendations for treating individuals with diabetes and hypertension, including selection of appropriate first-line therapies and additional agents when goals are not met
All physicians and allied health professionals interested in the study, diagnosis, and treatment of endocrine-related diseases.
The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.